Caprock Group LLC Takes Position in iShares Biotechnology ETF $IBB

Caprock Group LLC acquired a new position in iShares Biotechnology ETF (NASDAQ:IBB) in the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 3,553 shares of the financial services provider’s stock, valued at approximately $491,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Brighton Jones LLC purchased a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at $201,000. AQR Capital Management LLC acquired a new position in iShares Biotechnology ETF during the first quarter valued at $455,000. Millennium Management LLC lifted its stake in iShares Biotechnology ETF by 140.8% in the 1st quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock worth $5,330,000 after acquiring an additional 143,893 shares in the last quarter. Stephens Inc. AR boosted its position in iShares Biotechnology ETF by 9.7% during the 2nd quarter. Stephens Inc. AR now owns 5,312 shares of the financial services provider’s stock worth $672,000 after acquiring an additional 471 shares during the period. Finally, D.A. Davidson & CO. grew its stake in iShares Biotechnology ETF by 27.1% during the 2nd quarter. D.A. Davidson & CO. now owns 4,876 shares of the financial services provider’s stock valued at $617,000 after acquiring an additional 1,039 shares in the last quarter. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 0.9%

Shares of IBB opened at $174.02 on Wednesday. The business’s 50-day moving average is $171.87 and its 200-day moving average is $158.14. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $179.64.

iShares Biotechnology ETF Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 19th. Shareholders of record on Tuesday, December 16th were given a $0.1831 dividend. This represents a $0.73 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date was Tuesday, December 16th. This is a positive change from iShares Biotechnology ETF’s previous quarterly dividend of $0.08.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.